Abstract | PURPOSE OF REVIEW: This review summarizes the recent advances on pathogenesis of antibody-mediated disorders of the neuromuscular junction, and results of studies on clinical assessment and treatments. RECENT FINDINGS: SUMMARY: Developments in serological assays, particularly of cell-based assays, are continuing to improve the diagnosis and investigation of these conditions. Learning more on pathogenicity has helped us to apply newer therapies.
|
Authors | Maria Elena Farrugia, Angela Vincent |
Journal | Current opinion in neurology
(Curr Opin Neurol)
Vol. 23
Issue 5
Pg. 489-95
(Oct 2010)
ISSN: 1473-6551 [Electronic] England |
PMID | 20651592
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Autoantibodies
(immunology)
- Autoimmune Diseases
(immunology, physiopathology, therapy)
- Guillain-Barre Syndrome
(immunology, physiopathology, therapy)
- Humans
- Isaacs Syndrome
(immunology, physiopathology, therapy)
- Lambert-Eaton Myasthenic Syndrome
(immunology, physiopathology, therapy)
- Miller Fisher Syndrome
(immunology, physiopathology, therapy)
- Myasthenia Gravis
(pathology, physiopathology, therapy)
- Neuromuscular Junction Diseases
(immunology, physiopathology, therapy)
- Thymectomy
(adverse effects)
|